Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
23:50:52 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



Q:NVAX - NOVAVAX INC - http://www.novavax.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NVAX - Q2.04.89·4.940.34.93+0.224.74,667.921,75110,7954.84  4.94  4.689511.36  3.532419:57:01Apr 1515 min RT 2¢

Recent Trades - Last 10 of 10795
Time ETExPriceChangeVolume
19:57:01Q4.910.2033
19:52:22Q4.900.19100
19:48:41Q4.900.191
19:48:13Q4.890.181
19:41:37Q4.920.212
19:41:29Q4.940.231
19:33:39Q4.910.2010
19:23:09Q4.890.1866
19:03:49Q4.910.205
18:59:48Q4.910.2015

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-15 06:00U:NVAXNews ReleaseShah Capital nominates two highly qualified independent director candidates for Novavax
2024-04-01 08:00U:NVAXNews ReleaseNovavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
2024-02-29 16:02U:NVAXNews ReleaseNovavax to Participate in TD Cowen's 44th Annual Health Care Conference
2024-02-28 08:00U:NVAXNews ReleaseNovavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
2024-02-22 06:00U:NVAXNews ReleaseNovavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement
2024-02-20 09:25U:NVAXNews ReleaseNovavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024
2024-01-03 09:25U:NVAXNews ReleaseNovavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-18 08:00U:NVAXNews ReleaseNovavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan
2023-12-13 08:00U:NVAXNews ReleaseCanadians Can Help Protect Loved Ones as We Head into the Holiday Season
2023-12-05 16:01U:NVAXNews ReleaseNovavax's Updated COVID-19 Vaccine Now Authorized in Canada
2023-11-28 06:00U:NVAXNews ReleaseNovavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
2023-11-17 07:15U:NVAXNews ReleaseNovavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
2023-11-10 09:25U:NVAXNews ReleaseNovavax to Participate in Jefferies London Healthcare Conference
2023-11-09 08:00U:NVAXNews ReleaseNovavax Reports Third Quarter 2023 Financial Results and Operational Highlights
2023-11-02 09:25U:NVAXNews ReleaseNovavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023
2023-10-31 16:37U:NVAXNews ReleaseNovavax's Updated COVID-19 Vaccine Now Approved in the EU
2023-10-31 12:58U:NVAXNews ReleaseNovavax's Updated Nuvaxovid ¢ „ ¢ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU
2023-10-18 08:05U:NVAXNews ReleaseNovavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid ¢ „ ¢ ¢ – ¼ in United Kingdom
2023-10-18 08:00U:NVAXNews ReleaseNovavax's Prototype COVID-19 Vaccine Nuvaxovid ¢ „ ¢ Receives Full Approval in Singapore